SEC 13F Intelligence

Burrage Capital Management LLC / BDTX

Burrage Capital Management LLC’s Black Diamond Therapeutics I Position

Does Burrage Capital Management LLC own Black Diamond Therapeutics I (BDTX)? Not currently — the last reported position was 110.4K shares worth $1M in Q2 2021; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$1M
Q2 2021
Shares
110.4K
% of Portfolio
+1.35%
Quarters Held
3
position exited

Position History BDTX

Reported value by quarter
Q4 ’20: $1MQ4 ’20Q1 ’21: $3MQ1 ’21Q2 ’21: $1MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021110.4K$1M+1.35%
Q1 2021110.4K$3M+2.17%
Q4 202034.9K$1M+0.85%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Burrage Capital Management LLC’s full portfolio or all institutional holders of BDTX.